Better Health Whole Wellness Center
- Ketamine Therapy
- Psychedelic Therapy
- Erectile Dysfunction (ED) Treatment
Read the Psychedelic Therapy guide for the educational context behind this treatment category.
Philadelphia, PA
Psychedelic psychiatry in Philadelphia today means ketamine based treatment ordered by a psychiatrist or another licensed prescriber and delivered inside a licensed medical or mental health practice, since that is the legal form most clinics here can offer outside of a research trial. Classic psychedelics such as psilocybin or MDMA are not legally available in Pennsylvania outside of a clinical trial, so psychedelic therapy in Philadelphia generally means IV ketamine infusion, ketamine assisted psychotherapy (KAP), or supervised esketamine nasal spray.
Practices cluster around Center City, particularly near Rittenhouse Square and Washington Square West close to the Jefferson and Pennsylvania Hospital medical corridor, with additional offices in University City near Penn and Drexel. Patients coming from the western suburbs often travel in along the Schuylkill Expressway (I-76) from Main Line towns such as Bryn Mawr and Wayne, while City Avenue connects Philadelphia directly to Bala Cynwyd and Lower Merion. Confirm the exact office address before booking, since some Philadelphia practices run intake by phone from one location but see patients at another.
Locally, this care happens in a physician office or a dedicated infusion suite where a prescriber confirms eligibility and nurses or other clinical staff administer and monitor the medication. A first appointment typically covers psychiatric and medical history, current medications, prior treatment attempts and the symptoms, such as treatment resistant depression, PTSD or anxiety, the patient wants to address. Ketamine infusion and ketamine assisted psychotherapy are distinct services, and not every Philadelphia office provides both, so ask about the prescriber's credentials, the medication's source, and how risks are disclosed in writing. Ask whether a licensed psychotherapist leads preparation and integration, how side effects are documented after each visit, and what happens if symptoms do not improve. Request a written quote that separates evaluation, medication, monitoring and psychotherapy, since this care is largely billed directly to the patient.
Listings on this page are not ordered by payment. Featured placements are labeled and capped, Verified means credential checks rather than spend, and the directory is free for patients. Being listed here is not an endorsement of any provider. The national psychedelic therapy hub covers mechanisms and evidence in more depth. Before comparing entries, read How to read a Regenerated city hub and Featured vs Verified vs organic.
Regulatory context
Ketamine is a DEA Schedule III controlled substance, FDA-approved as a dissociative anesthetic and used off-label for treatment-resistant depression, PTSD, and chronic pain. The FDA approved esketamine (Spravato) in 2019 for treatment-resistant depression under a Risk Evaluation and Mitigation Strategy (REMS) program that requires in-office administration at certified sites. MDMA-assisted therapy remains Schedule I; the FDA issued a Complete Response Letter in August 2024 to Lykos Therapeutics on its MDMA new drug application. Psilocybin is Schedule I and holds FDA Breakthrough Therapy designation through sponsors such as Compass Pathways and Usona, but has not received FDA approval. Oregon Measure 109 (passed 2020, operational 2023) created a state psilocybin service center framework, and Colorado Proposition 122 (2022) authorized regulated healing centers.
Pennsylvania enforces federal scheduling. The Pennsylvania State Board of Medicine oversees prescriber conduct. DEA enforcement on ketamine clinics focuses on diversion and Ryan Haight Act telehealth rules. Pennsylvania PDMP requires controlled substance reporting.
Explore nearby
Available here
Explore statewide
Psychedelic Therapy in PennsylvaniaNationwide
Psychedelic Therapy clinics across the US